QBFM
OSIR

QS Batterymarch Financial Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

QS Batterymarch Financial Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$895K Buy
71,037
+25,546
+56% +$364K 0.02% 546
2014
Q2 		$711K Sell
45,491
-2,750
-6% -$40.4K 0.02% 566
2014
Q1 		$634K Buy
+48,241
New +$755K 0.01% 707

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

QS Batterymarch Financial Management's OSIR Position: Q3 2014 in Review

QS Batterymarch Financial Management increased its Osiris Therapeutics, Inc. Common Stock (OSIR) stake by 56% in Q3 2014, buying an estimated $364K and bringing the position to 71,037 shares worth $895K. The position accounts for 0.02% of the portfolio, ranked #546.

QS Batterymarch Financial Management first reported a position in OSIR in Q1 2014 and has held it in 3 quarters since. 67 funds tracked by Wall St. Rank hold OSIR as of Q3 2014.

  • QS Batterymarch Financial Management held 71,037 shares of Osiris Therapeutics, Inc. Common Stock worth $895K as of Q3 2014.
  • QS Batterymarch Financial Management bought 25,546 Osiris Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $364K.
  • Osiris Therapeutics, Inc. Common Stock made up 0.02% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #546 holding.
  • QS Batterymarch Financial Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2014 and has held it in 3 quarters since.
  • 67 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.